Mosca et al. compared the levels of HIF-1α pre- and post-tendinopathy treatment and found that the levels of HIF-1α were increased in diseased tendons when compared to post-treatment and healthy tendons (Table 1) [55]. This evidence concerns the gene HIF1A and disease of the tendon.